Barbara W. Bodem
Director · BIOMARIN PHARMACEUTICAL INC
Individual
- 2025
- Jun 4, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Barbara W. Bodem files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- George Eric Davis - $2.76M in BMRN purchases and sales in the last 12 months
- Harry M. Jansen Kraemer Jr. - $1.77M in OPCH purchases and sales in the last 12 months
- Charles Greg Guyer - $997K in BMRN purchases and sales in the last 12 months
- R. Carter Pate - $971K in OPCH purchases and sales in the last 12 months
- Gregory R. Friberg - $559K in BMRN purchases and sales in the last 12 months
- Timothy P. Sullivan - $500K in OPCH purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Barbara W. Bodem?
Barbara W. Bodem is a corporate insider, tracked as Director of BIOMARIN PHARMACEUTICAL INC (BMRN). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Barbara W. Bodem last file a Form 4?
The most recent primary Form 4 on record is dated 4 June 2026, one of 5 filings going back to 2025.
